Loading data
DXCMNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 4.66 bn USD | 4.03 bn USD | 3.62 bn USD | 2.91 bn USD | 2.45 bn USD |
| Cost of revenue | 1.86 bn USD | 1.59 bn USD | 1.33 bn USD | 1.03 bn USD | 768 m USD |
| Gross profit | 2.8 bn USD | 2.44 bn USD | 2.29 bn USD | 1.88 bn USD | 1.68 bn USD |
| Research and development expense | 599.1 m USD | 552.4 m USD | 505.8 m USD | 484.2 m USD | 517.1 m USD |
| Selling, general and administrative expense | 1.29 bn USD | 1.29 bn USD | 1.19 bn USD | 1.01 bn USD | 810.5 m USD |
| Operating profit | 911.8 m USD | 600 m USD | 597.7 m USD | 391.2 m USD | 265.8 m USD |
| Interest expense | — | — | 20.3 m USD | 18.6 m USD | 18.8 m USD |
| Profit before tax | 1.09 bn USD | 709 m USD | 710.4 m USD | 390.8 m USD | 256.8 m USD |
| Income tax expense | 252.1 m USD | 132.8 m USD | 168.9 m USD | 49.6 m USD | 39.9 m USD |
| Net income (reported basis) | 836.3 m USD | 576.2 m USD | 541.5 m USD | 341.2 m USD | 216.9 m USD |
| Basic earnings per share | 2.14 USD/share | 1.46 USD/share | 1.4 USD/share | 0.88 USD/share | 0.56 USD/share |
| Diluted earnings per share | 2.09 USD/share | 1.42 USD/share | 1.3 USD/share | 0.82 USD/share | 0.53 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.